In one paragraphArticle in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from itWhat it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
13 authors.
Lan QianAbboud Cardiovascular Research Center, Division of Cardiovascular Medicine, Department of Internal Medicine, Carver College of Medicine, University of Iowa, Iowa City IA 52242, USA.
Olha M KovalAbboud Cardiovascular Research Center, Division of Cardiovascular Medicine, Department of Internal Medicine, Carver College of Medicine, University of Iowa, Iowa City IA 52242, USA.ORCID 0000-0003-1644-0046 Benney T EndoniAbboud Cardiovascular Research Center, Division of Cardiovascular Medicine, Department of Internal Medicine, Carver College of Medicine, University of Iowa, Iowa City IA 52242, USA.ORCID 0000-0003-1078-3654 Denise JuhrAbboud Cardiovascular Research Center, Division of Cardiovascular Medicine, Department of Internal Medicine, Carver College of Medicine, University of Iowa, Iowa City IA 52242, USA.ORCID 0009-0009-8089-7818 Colleen S SteinAbboud Cardiovascular Research Center, Division of Cardiovascular Medicine, Department of Internal Medicine, Carver College of Medicine, University of Iowa, Iowa City IA 52242, USA.
Chantal AllamargotCentral Microscopy Research Facility, University of Iowa.
Li-Hsien LinAbboud Cardiovascular Research Center, Division of Cardiovascular Medicine, Department of Internal Medicine, Carver College of Medicine, University of Iowa, Iowa City IA 52242, USA.
Deng-Fu GuoDepartment of Neuroscience and Pharmacology, University of Iowa.
Kamal RahmouniAbboud Cardiovascular Research Center, Division of Cardiovascular Medicine, Department of Internal Medicine, Carver College of Medicine, University of Iowa, Iowa City IA 52242, USA.ORCID 0000-0001-5136-6748 Ryan L BoudreauAbboud Cardiovascular Research Center, Division of Cardiovascular Medicine, Department of Internal Medicine, Carver College of Medicine, University of Iowa, Iowa City IA 52242, USA.ORCID 0000-0002-9800-5349 Jennifer StreeterAbboud Cardiovascular Research Center, Division of Cardiovascular Medicine, Department of Internal Medicine, Carver College of Medicine, University of Iowa, Iowa City IA 52242, USA.
William H ThielAbboud Cardiovascular Research Center, Division of Cardiovascular Medicine, Department of Internal Medicine, Carver College of Medicine, University of Iowa, Iowa City IA 52242, USA.ORCID 0000-0002-2372-2925 Isabella M GrumbachAbboud Cardiovascular Research Center, Division of Cardiovascular Medicine, Department of Internal Medicine, Carver College of Medicine, University of Iowa, Iowa City IA 52242, USA.ORCID 0000-0002-2285-3157 Funding
Mitochondrial CaMKII drives smooth muscle migration and neointimal hyperplasiaR01HL108932 · NHLBI · UNIVERSITY OF IOWA · PI GRUMBACH, ISABELLA MARIA · 2012 to 2021
$3.6MLeveraging the mitochondrial regulator MIRO1 to prevent neointimal hyperplasiaR01HL157956 · NHLBI · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI GRUMBACH, ISABELLA MARIA · 2022 to 2025
$2.4MRole of FGF21 Action in Hypothalamic Neurons in Obesity-Associated HypertensionR01HL162773 · NHLBI · UNIVERSITY OF IOWA · PI KAMAL RAHMOUNI · 2023 to 2026
$2.4MThe physiologic and genomic relevance of mitoregulin in ischemic heart failureR01HL150557 · NHLBI · UNIVERSITY OF IOWA · PI BOUDREAU, RYAN L · 2020 to 2023
$1.5MNeuronal Mechanisms of Obesity-Induced HypertensionI01BX004249 · VA · IOWA CITY VA MEDICAL CENTER · PI KAMAL RAHMOUNI · 2019 to 2026
–BLRD Research Career Scientist Award ApplicationIK6BX006040 · VA · IOWA CITY VA MEDICAL CENTER · PI RAHMOUNI, KAMAL · 2022 to 2025
–Mitochondrial CAMKII in smooth muscle as key regulator of hypertension and vascular remodelingI01BX000163 · VA · OKLAHOMA CITY VA MEDICAL CENTER · PI Isabella Maria Grumbach · 2011 to 2026
–BLRD VA I01 BX000163BLRD VA I01 BX004249BLRD VA IK6 BX006040NHLBI NIH HHS R01 HL108932NHLBI NIH HHS R01 HL150557NHLBI NIH HHS R01 HL157956NHLBI NIH HHS R01 HL162773
6 · The paper itselfAbstract
Background: The outer mitochondrial Rho GTPase 1, MIRO1, mediates mitochondrial motility within cells, but implications for vascular smooth muscle cell (VSMC) physiology and its roles in vascular diseases, such as neointima formation following vascular injury are widely unknown. Methods: Carotid ligation was performed in an in vivo model of selective Miro1 deletion in smooth muscle cells. VSMC proliferation during the cell cycle and molecular mechanisms of smooth muscle cell proliferation were explored in cultured aortic VSMCs by imaging mitochondrial positioning and cristae structure and assessing the effects on ATP production, metabolic function and interactions with components of the electron transport chain (ETC). MIRO1 expression was analyzed in human coronary arteries, and its function was assessed via knockdown in human coronary artery VSMCs. Results: Results revealed strong MIRO1 expression in VSMCs within human atherosclerotic plaques. MIRO1 facilitated VSMC proliferation and neointima formation by regulating mitochondrial positioning and PDGF-stimulated ATP production and respiration, critical for cell-cycle progression at G1/S. Deletion of Miro1 disrupted mitochondrial cristae structure, diminished ETC complex I activity, and impaired super complex formation. Notably, restoring MIRO1 function with a mutant lacking EF hands, which are essential for mitochondrial mobility, only partially rescued these effects. MIRO1 knockdown in human coronary artery VSMCs confirmed its pivotal role in mitochondrial function and VSMC proliferation. Conclusions: This study highlights two key mechanisms by which MIRO1 regulates VSMC proliferation. First, it maintains ATP synthesis by preserving mitochondrial cristae integrity. Second, its Ca
Indexed as
electron transport chainMIRO1Mitochondrianeointimaproliferationsmooth muscle
Identifiers
PMID39185180
PMCPMC11343164
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC
Read underepoch 390